BIO UV: 2021 Annual Results: New Proforma Dimensions by Corelec-2022/04/06 6:00 pm

  • 44.4 million euros

    Proformer sales

  • 16.8%

    Proformer EBITDA Margin

  • 7.4%

    Proformer Net Income

  • Proposed payments to shareholders

    0.05 euros per share

    Will be deducted from the issue premium

During the meeting on April 4, 2022,

BIO-UV Group (Euronext Growth



Experts in water treatment and disinfection systems with UV, ozone, salt electrolysis and AOP have approved the 2021 annual accounting, which was closed on 31 December 2021. The audit procedure for accounting has been performed and a certification report has been issued. Legal auditor. The 2021 Fiscal Year Annual Report will soon be available on the BIO-UV website,, Investor Area,[ドキュメント]It will be available on the tab.

Income statement as of December 31

M € data-French standard

Fiscal year 2020

(Integrated for 12 months)

Fiscal year 2021



12 months)


Fiscal year 2021



12 months)

turn over



+ 4%




3.3 3.3


+ 19%

7.5 7.5

EBITDA margin



+ 140bp


Net depreciation. And prov.




Business results

1.4 1.4

1.0 1.0


Net income (group share)

0.6 0.6


+ 18%

3.3 3.3

Net profit margin



+30 bps



Corelec has been integrated into group accounts since 1 year


November 2021.


By integrating Corelec over the 12 months (from 1) of the past fiscal year


January-31st, 2021).


EBITDA: Operating profit + depreciation and post-cancellation allowance.

In fiscal year 2021, the BIO-UV Group recorded consolidated sales of € 33.5 million.

Acquired in November 2021 and integrated during the two least-contributory months of the fiscal year, taking into account the seasonality of swimming pools, Corelec contributed € 1 million to integrated revenue. Overall in 2021, Corelec achieved annual revenue of € 11.9 million, a significant increase of + 101% compared to 2020.

Proforma-based, Corelec integrated for 12 months,

BIO-UV Group’s 2021 sales will reach € 44.4 million

Reflects the dimension changes made at the end of the fiscal year.

12.0% EBITDA margin
2021 (excluding Corelec)

At the end of fiscal year 2021, EBITDA was up 19% to € 3.9 million in consolidated data.

Excluding Corelec, the 2021 EBITDA margin is 12.0%.

After considering the financial results consisting of interest and foreign exchange gains, and the exceptional results limited to -0.1 million euros

Net profit, group share of 700,000 euros,

It increased by + 18% in 2021. Therefore, the net profit margin in 2021 will be 2.1% compared to 1.8% in 2020.

16.8% Proforma EBITDA Margin

Corelec achieved an EBITDA of € 3.6 million in 2021. This corresponds to an EBITDA margin of 30.0%.

On a proforma basis,

The new entity’s EBITDA was € 7.5 million in 2021 with a 16.8% EBITDA margin.

The estimated operating profit was 4.6 million euros and the operating margin was 10.4%.


Proforma net profit is 3.3 million euros

Including corporate tax of 600,000 euros, ie

7.4% Proforma Net Income


Operating cash flow of € 3.3 million in 2021 excluding scope effect

BIO-UV generated total cash flow of € 3.6 million in 2021, up 55% compared to the fiscal year (€ 2.4 million in 2020) and fluctuations in sales of € -0.3 million (Euro 0.3 million). In 2020 it was limited to -2.5 million euros). ) Excludes scope effects.In this way, BIO-UV

Strong operating cash flow of +3.3 million euros

2021 excluding scope effect (compared to -0.1 million euros in 2020).

The investment business has consumed € 29.3 million. This includes € 26.7 million on the acquisition of Corelec and € 2.7 million on CAPEX (Acquisition of Fixed Assets) to pursue group structuring and certification of new systems.

The acquisition of Corelec was funded by setting up a new loan of € 18.0 million, including a bank debt of € 13.0 million and a bond of € 5 million. At the same time, BIO-UV repaid the loan for € 2 million.

Net financial debt as of December 31, 2021


Was € 27.6 million and shareholders’ equity was € 30.8 million (compared to € 30.2 million at the end of 2020).

Proposed payment to shareholders of € 0.05 per share

Given the strong performance and sound financial structure of BIO-UV in 2021, the Board of Directors on April 4, 2022 proposed to pay the amount in cash at the shareholders’ meeting on May 25, 2022. I decided to do it. 0.05 per share deducted from the issuance premium for fiscal year 2021. Subject to a vote in favor of shareholders at the General Assembly, this payment separation will take place on June 28, 2022 and the settlement will take place on June 30, 2022. ..

This 1


The proposed payments to shareholders in the history of BIO-UV underscore the company’s desire to follow regular distribution policies over the next few years.

Proformer sales increased by 23% in one year


2022 quarter

Despite the conflict in Ukraine and the still strong tensions in the supply chain, BIO-UV got off to a good start in Fiscal 2022 for both its historic scope and the Corelec company.

After 1


Quarterly, groups are lined up

+ 23% proforma growth (due to Corelec integration)

..In the historical range (excluding Corelec), the group

+ 15% Quarterly Organic Growth

, With the sustainable growth of the activities of the maritime sector. The latter benefits from both postponement of orders and deliveries from 2021 and a strong market due to the strengthening of the team.

In addition, Corelec integration is on track.

Geopolitical situation Russia-Ukraine

Regarding the conflict in Ukraine, the group produced about 1% of its activities in Russia, Belarus and Ukraine in 2021.

BIO-UV has no production bases or employees exposed to the region and does not purchase directly with suppliers in these countries.

Outlook 2022

Considering the sales achieved in 1


Quarters and orders are already signed and will be delivered on the 2nd


Quarterly billing amount of 1


Semester 2022 is already at level 1


Half of 2021 (including Corelec), or about 23 million euros.You need to add an invoice for the order that comes between 2 to this amount



Despite the problematic situation, this year should be characterized by the continued dynamic growth of activities, accelerated by Corelec’s contributions.

Benoit Gillmann, Founder and Chairman of the BIO-UV Group-Managing Director, declares:


Evolving in a complex market of more than two years with the addition of the geopolitical crisis in early 2022, I would like to thank and congratulate all the teams.

BIO-UV was evaluated for its efficiency, mobilization, and motivation in Lunel and Muret, France, and Glasgow, Scotland. This effort has given us a great year in 2021 and a promising start to growth towards 2022.

Fiscal 2021 is certainly notable for the growth achieved, with the Group’s new real range sales of € 44.4 million, as well as EBITDA of € 7.5 million, or an EBITDA margin of 16.8%. Deserves. Based on these results, 1


At the next General Meeting of Shareholders, we will propose to pay a bonus of € 0.05 per share and mark the start of our distribution policy as a thank you to our shareholders. This year, 2021, through the acquisition of Corelec, it has established a strong position in the recreation market, with the aquaculture market, industrial processes and especially wastewater (“reuse”).

Finally, I would like to reiterate the real blue gold, which is an important position of BIO-UV in the water market. Nothing is more essential to life. It is impossible to live without drinking water and without treated or reprocessed water. With the technology designed, manufactured and sold by BIO-UV, “these waters” can be made healthy without the use of chemicals. This absolute need puts us in an important strategic area for lasting and sustainable growth. The key issue expressed by the equation “population grows and drinks less” directly affects the activities of well-known companies that have mastered these treatment techniques, such as BIO-UV. Therefore, BIO-UV is at the heart of environmental and sustainable themes. »»

Financial diary



2022 Semi-Annual Revenue

July 20, 2022

Results for the second half of 2022

September 21, 2022

2022 annual sales

January 25, 2023

2022 annual results

April 5, 2023

All publications will be made after the closure of the Euronext Paris market.

About BIO-UV Group

Founded in 2000, the BIO-UV Group designs, manufactures and sells innovative water disinfection systems that use UV, salt electrolysis, ozone and AOP (advanced oxidation process).

Listed on the Euronext market


Growth in Paris (FR0013345493-ALTUV), BIO-UV Group, labeled Innovative Company by Bpifrance, is subject to the PEA-PME scheme.

contact address:

BIO-UV group

+33 (0) 4 99 13 39 11

[email protected]

Investor public relations

Matthew Omnis-News

+33 (0) 1 53 67 36 92

[email protected]

Public relations

Serena Boni-News

+33 (0) 4 4 72 18 04 92

[email protected]


EBITDA: Operating profit + depreciation and post-cancellation allowance.


By integrating Corelec over the 12 months (from 1) of the past fiscal year


January-31st, 2021).


Net Financial Debt = Borrowing and Financial Debt (excluding Finance Lease Loans) + Other Financial Debt – Available Cash

This post has a “🔒 Actusnews SECURITY MASTER” service.

-Security Master Key:


-To verify this key:

Regulatory information:

Inside information:

-Account, press release on results

Complete original press release in PDF format:

© Copyright ActusnewsWire

Sign up for and receive your company’s next press release for free by email.